JBC Advanced Peptides, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M905763199 on March 9, 2000

J. Biol. Chem., Vol. 275, Issue 21, 15948-15954, May 26, 2000
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/21/15948    most recent
M905763199v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fayadat, L.
Right arrow Articles by Franc, J.-L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fayadat, L.
Right arrow Articles by Franc, J.-L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Degradation of Human Thyroperoxidase in the Endoplasmic Reticulum Involves Two Different Pathways Depending on the Folding State of the Protein*

Laurence FayadatDagger §, Sandrine Siffroi-FernandezDagger , Jeanne Lanet, and Jean-Louis Franc

From the U38 INSERM, Faculté de Médecine, Université de la Méditerranée, 13385 Marseille cedex 5, France

Human thyroperoxidase (hTPO), a type I transmembrane glycoprotein, plays a key role in thyroid hormone synthesis. In a previous paper (Fayadat, L., Niccoli, P., Lanet, J., and Franc, J. L. (1998) Endocrinology 139, 4277-4285) we established that after the synthesis, only 15-20% of the hTPO molecules were recognized by a monoclonal antibody (mAb15) directed against a conformational structure and that only 2% were able to reach the cell surface. In the present study using pulse-chase experiments in the presence or absence of protease inhibitors followed by immunoprecipitation procedures with monoclonal antibodies recognizing unfolded or partially folded hTPO forms we show that: (i) unfolded hTPO forms are degraded by the proteasome and (ii) partially folded hTPO forms are degraded by other proteases. It was also established upon incubating endoplasmic reticulum (ER) membranes in vitro that the degradation of the partially folded hTPO was carried out by serine and cysteine integral ER membrane proteases. These data provide valuable insights into the quality control mechanisms whereby the cells get rid of misfolded or unfolded proteins. Moreover, this is the first study describing a protein degradation process involving two distinct degradation pathways (proteasome and ER cysteine/serine proteases) at the ER level, depending on the folding state of the protein.


* This work was supported by INSERM (U38) and by the Association pour la Recherche sur le Cancer.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Supported during this work by the Association pour le Developpement des Recherches Biologiques et Médicales.

§ Present address: Dept. of Biological Sciences, Stanford University, Stanford, CA 94305-5020.

To whom correspondence should be addressed: U38 INSERM, Faculté de Médecine, 27 Bd J. Moulin, 13385 Marseille cedex 5, France. Tel.: 33-4-91-32-43-77; Fax: 33-4-91-79-65-11; E-mail: jean-louis.franc@medecine.univ-mrs.fr.


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Cell Sci.Home page
I. Shapira, D. Charuvi, Y. Elkabetz, K. Hirschberg, and S. Bar-Nun
Distinguishing between retention signals and degrons acting in ERAD
J. Cell Sci., December 15, 2007; 120(24): 4377 - 4387.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Giraud, P.-J. Lejeune, J. Barbaria, and B. Mallet
A Plasminogen-Like Protease in Thyroid Rough Microsomes Degrades Thyroperoxidase and Thyroglobulin
Endocrinology, June 1, 2007; 148(6): 2886 - 2893.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
H. Kato, K. Sakaki, and K. Mihara
Ubiquitin-proteasome-dependent degradation of mammalian ER stearoyl-CoA desaturase
J. Cell Sci., June 1, 2006; 119(11): 2342 - 2353.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
F.-F. Yan, C.-W. Lin, E. A. Cartier, and S.-L. Shyng
Role of ubiquitin-proteasome degradation pathway in biogenesis efficiency of {beta}-cell ATP-sensitive potassium channels
Am J Physiol Cell Physiol, November 1, 2005; 289(5): C1351 - C1359.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Kuliawat, J. Ramos-Castaneda, Y. Liu, and P. Arvan
Intracellular Trafficking of Thyroid Peroxidase to the Cell Surface
J. Biol. Chem., July 29, 2005; 280(30): 27713 - 27718.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Le Fourn, M. Ferrand, and J.-L. Franc
Endoproteolytic Cleavage of Human Thyroperoxidase: ROLE OF THE PROPEPTIDE IN THE PROTEIN FOLDING PROCESS
J. Biol. Chem., February 11, 2005; 280(6): 4568 - 4577.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
S. Duvet, F. Foulquier, A.-M. Mir, F. Chirat, and R. Cacan
Discrimination between lumenal and cytosolic sites of deglycosylation in endoplasmic reticulum-associated degradation of glycoproteins by using benzyl mannose in CHO cell lines
Glycobiology, September 1, 2004; 14(9): 841 - 849.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Mancini, M. Aebi, and A. Helenius
Multiple Endoplasmic Reticulum-associated Pathways Degrade Mutant Yeast Carboxypeptidase Y in Mammalian Cells
J. Biol. Chem., November 21, 2003; 278(47): 46895 - 46905.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
O. Ben-Zeev, H. Z. Mao, and M. H. Doolittle
Maturation of Lipoprotein Lipase in the Endoplasmic Reticulum. CONCURRENT FORMATION OF FUNCTIONAL DIMERS AND INACTIVE AGGREGATES
J. Biol. Chem., March 15, 2002; 277(12): 10727 - 10738.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
M. J. Spiro and R. G. Spiro
Release of polymannose oligosaccharides from vesicular stomatitis virus G protein during endoplasmic reticulum-associated degradation
Glycobiology, October 1, 2001; 11(10): 803 - 811.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
Y. Zhang, G. Nijbroek, M. L. Sullivan, A. A. McCracken, S. C. Watkins, S. Michaelis, and J. L. Brodsky
Hsp70 Molecular Chaperone Facilitates Endoplasmic Reticulum-associated Protein Degradation of Cystic Fibrosis Transmembrane Conductance Regulator in Yeast
Mol. Biol. Cell, May 1, 2001; 12(5): 1303 - 1314.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
X. Zhang and P. Arvan
Cell Type-dependent Differences in Thyroid Peroxidase Cell Surface Expression
J. Biol. Chem., October 6, 2000; 275(41): 31946 - 31953.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.